Global Macular Degeneration (AMD) and Other Retinal Diseases Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size 2017-2028

2.1.2 Macular Degeneration (AMD) and Other Retinal Diseases Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Macular Degeneration (AMD) and Other Retinal Diseases Segment by Type

2.2.1 Macular Degeneration

2.2.2 Diabetic Macular Edema

2.2.3 Diabetic Retinopathy(DR)

2.2.4 Retinal Vein Occlusion

2.2.5 Wet Age-Related Macular Degeneration (wAMD)

2.2.6 Dry Age-Related Macular Degeneration (dAMD)

2.2.7 Other

2.3 Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Type

2.3.1 Macular Degeneration (AMD) and Other Retinal Diseases Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size Market Share by Type (2017-2022)

2.4 Macular Degeneration (AMD) and Other Retinal Diseases Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Other

2.5 Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Application

2.5.1 Macular Degeneration (AMD) and Other Retinal Diseases Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size Market Share by Application (2017-2022)

3 Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Player

3.1 Macular Degeneration (AMD) and Other Retinal Diseases Market Size Market Share by Players

3.1.1 Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue by Players (2020-2022)

3.1.2 Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue Market Share by Players (2020-2022)

3.2 Global Macular Degeneration (AMD) and Other Retinal Diseases Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Macular Degeneration (AMD) and Other Retinal Diseases by Regions

4.1 Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Regions (2017-2022)

4.2 Americas Macular Degeneration (AMD) and Other Retinal Diseases Market Size Growth (2017-2022)

4.3 APAC Macular Degeneration (AMD) and Other Retinal Diseases Market Size Growth (2017-2022)

4.4 Europe Macular Degeneration (AMD) and Other Retinal Diseases Market Size Growth (2017-2022)

4.5 Middle East & Africa Macular Degeneration (AMD) and Other Retinal Diseases Market Size Growth (2017-2022)

5 Americas

5.1 Americas Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Country (2017-2022)

5.2 Americas Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Type (2017-2022)

5.3 Americas Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Region (2017-2022)

6.2 APAC Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Type (2017-2022)

6.3 APAC Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Macular Degeneration (AMD) and Other Retinal Diseases by Country (2017-2022)

7.2 Europe Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Type (2017-2022)

7.3 Europe Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Macular Degeneration (AMD) and Other Retinal Diseases by Region (2017-2022)

8.2 Middle East & Africa Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Type (2017-2022)

8.3 Middle East & Africa Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Macular Degeneration (AMD) and Other Retinal Diseases Market Forecast

10.1 Global Macular Degeneration (AMD) and Other Retinal Diseases Forecast by Regions (2023-2028)

10.1.1 Global Macular Degeneration (AMD) and Other Retinal Diseases Forecast by Regions (2023-2028)

10.1.2 Americas Macular Degeneration (AMD) and Other Retinal Diseases Forecast

10.1.3 APAC Macular Degeneration (AMD) and Other Retinal Diseases Forecast

10.1.4 Europe Macular Degeneration (AMD) and Other Retinal Diseases Forecast

10.1.5 Middle East & Africa Macular Degeneration (AMD) and Other Retinal Diseases Forecast

10.2 Americas Macular Degeneration (AMD) and Other Retinal Diseases Forecast by Country (2023-2028)

10.2.1 United States Macular Degeneration (AMD) and Other Retinal Diseases Market Forecast

10.2.2 Canada Macular Degeneration (AMD) and Other Retinal Diseases Market Forecast

10.2.3 Mexico Macular Degeneration (AMD) and Other Retinal Diseases Market Forecast

10.2.4 Brazil Macular Degeneration (AMD) and Other Retinal Diseases Market Forecast

10.3 APAC Macular Degeneration (AMD) and Other Retinal Diseases Forecast by Region (2023-2028)

10.3.1 China Macular Degeneration (AMD) and Other Retinal Diseases Market Forecast

10.3.2 Japan Macular Degeneration (AMD) and Other Retinal Diseases Market Forecast

10.3.3 Korea Macular Degeneration (AMD) and Other Retinal Diseases Market Forecast

10.3.4 Southeast Asia Macular Degeneration (AMD) and Other Retinal Diseases Market Forecast

10.3.5 India Macular Degeneration (AMD) and Other Retinal Diseases Market Forecast

10.3.6 Australia Macular Degeneration (AMD) and Other Retinal Diseases Market Forecast

10.4 Europe Macular Degeneration (AMD) and Other Retinal Diseases Forecast by Country (2023-2028)

10.4.1 Germany Macular Degeneration (AMD) and Other Retinal Diseases Market Forecast

10.4.2 France Macular Degeneration (AMD) and Other Retinal Diseases Market Forecast

10.4.3 UK Macular Degeneration (AMD) and Other Retinal Diseases Market Forecast

10.4.4 Italy Macular Degeneration (AMD) and Other Retinal Diseases Market Forecast

10.4.5 Russia Macular Degeneration (AMD) and Other Retinal Diseases Market Forecast

10.5 Middle East & Africa Macular Degeneration (AMD) and Other Retinal Diseases Forecast by Region (2023-2028)

10.5.1 Egypt Macular Degeneration (AMD) and Other Retinal Diseases Market Forecast

10.5.2 South Africa Macular Degeneration (AMD) and Other Retinal Diseases Market Forecast

10.5.3 Israel Macular Degeneration (AMD) and Other Retinal Diseases Market Forecast

10.5.4 Turkey Macular Degeneration (AMD) and Other Retinal Diseases Market Forecast

10.5.5 GCC Countries Macular Degeneration (AMD) and Other Retinal Diseases Market Forecast

10.6 Global Macular Degeneration (AMD) and Other Retinal Diseases Forecast by Type (2023-2028)

10.7 Global Macular Degeneration (AMD) and Other Retinal Diseases Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Regeneron Pharmaceuticals

11.1.1 Regeneron Pharmaceuticals Company Information

11.1.2 Regeneron Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Product Offered

11.1.3 Regeneron Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Regeneron Pharmaceuticals Main Business Overview

11.1.5 Regeneron Pharmaceuticals Latest Developments

11.2 Bayer HealthCare

11.2.1 Bayer HealthCare Company Information

11.2.2 Bayer HealthCare Macular Degeneration (AMD) and Other Retinal Diseases Product Offered

11.2.3 Bayer HealthCare Macular Degeneration (AMD) and Other Retinal Diseases Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Bayer HealthCare Main Business Overview

11.2.5 Bayer HealthCare Latest Developments

11.3 Novartis

11.3.1 Novartis Company Information

11.3.2 Novartis Macular Degeneration (AMD) and Other Retinal Diseases Product Offered

11.3.3 Novartis Macular Degeneration (AMD) and Other Retinal Diseases Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Novartis Main Business Overview

11.3.5 Novartis Latest Developments

11.4 Roche

11.4.1 Roche Company Information

11.4.2 Roche Macular Degeneration (AMD) and Other Retinal Diseases Product Offered

11.4.3 Roche Macular Degeneration (AMD) and Other Retinal Diseases Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Roche Main Business Overview

11.4.5 Roche Latest Developments

11.5 Kanghong Pharma

11.5.1 Kanghong Pharma Company Information

11.5.2 Kanghong Pharma Macular Degeneration (AMD) and Other Retinal Diseases Product Offered

11.5.3 Kanghong Pharma Macular Degeneration (AMD) and Other Retinal Diseases Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Kanghong Pharma Main Business Overview

11.5.5 Kanghong Pharma Latest Developments

11.6 Merck

11.6.1 Merck Company Information

11.6.2 Merck Macular Degeneration (AMD) and Other Retinal Diseases Product Offered

11.6.3 Merck Macular Degeneration (AMD) and Other Retinal Diseases Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Merck Main Business Overview

11.6.5 Merck Latest Developments

11.7 Allergan

11.7.1 Allergan Company Information

11.7.2 Allergan Macular Degeneration (AMD) and Other Retinal Diseases Product Offered

11.7.3 Allergan Macular Degeneration (AMD) and Other Retinal Diseases Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Allergan Main Business Overview

11.7.5 Allergan Latest Developments

11.8 Santen Pharmaceutical

11.8.1 Santen Pharmaceutical Company Information

11.8.2 Santen Pharmaceutical Macular Degeneration (AMD) and Other Retinal Diseases Product Offered

11.8.3 Santen Pharmaceutical Macular Degeneration (AMD) and Other Retinal Diseases Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Santen Pharmaceutical Main Business Overview

11.8.5 Santen Pharmaceutical Latest Developments

11.9 GlaxoSmithKline Pharmaceuticals

11.9.1 GlaxoSmithKline Pharmaceuticals Company Information

11.9.2 GlaxoSmithKline Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Product Offered

11.9.3 GlaxoSmithKline Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 GlaxoSmithKline Pharmaceuticals Main Business Overview

11.9.5 GlaxoSmithKline Pharmaceuticals Latest Developments

11.10 Pfizer

11.10.1 Pfizer Company Information

11.10.2 Pfizer Macular Degeneration (AMD) and Other Retinal Diseases Product Offered

11.10.3 Pfizer Macular Degeneration (AMD) and Other Retinal Diseases Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Pfizer Main Business Overview

11.10.5 Pfizer Latest Developments

11.11 Acucela

11.11.1 Acucela Company Information

11.11.2 Acucela Macular Degeneration (AMD) and Other Retinal Diseases Product Offered

11.11.3 Acucela Macular Degeneration (AMD) and Other Retinal Diseases Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Acucela Main Business Overview

11.11.5 Acucela Latest Developments

11.12 Valent Pharmaceuticals

11.12.1 Valent Pharmaceuticals Company Information

11.12.2 Valent Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Product Offered

11.12.3 Valent Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Valent Pharmaceuticals Main Business Overview

11.12.5 Valent Pharmaceuticals Latest Developments

11.13 IVERIC

11.13.1 IVERIC Company Information

11.13.2 IVERIC Macular Degeneration (AMD) and Other Retinal Diseases Product Offered

11.13.3 IVERIC Macular Degeneration (AMD) and Other Retinal Diseases Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 IVERIC Main Business Overview

11.13.5 IVERIC Latest Developments

12 Research Findings and Conclusion

Table 1. Macular Degeneration (AMD) and Other Retinal Diseases Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Macular Degeneration

Table 3. Major Players of Diabetic Macular Edema

Table 4. Major Players of Diabetic Retinopathy(DR)

Table 5. Major Players of Retinal Vein Occlusion

Table 6. Major Players of Wet Age-Related Macular Degeneration (wAMD)

Table 7. Major Players of Dry Age-Related Macular Degeneration (dAMD)

Table 8. Major Players of Other

Table 9. Macular Degeneration (AMD) and Other Retinal Diseases Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 10. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Type (2017-2022) & ($ Millions)

Table 11. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size Market Share by Type (2017-2022)

Table 12. Macular Degeneration (AMD) and Other Retinal Diseases Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 13. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Application (2017-2022) & ($ Millions)

Table 14. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size Market Share by Application (2017-2022)

Table 15. Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue by Players (2020-2022) & ($ Millions)

Table 16. Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue Market Share by Player (2020-2022)

Table 17. Macular Degeneration (AMD) and Other Retinal Diseases Key Players Head office and Products Offered

Table 18. Macular Degeneration (AMD) and Other Retinal Diseases Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 19. New Products and Potential Entrants

Table 20. Mergers & Acquisitions, Expansion

Table 21. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Regions 2017-2022 & ($ Millions)

Table 22. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size Market Share by Regions (2017-2022)

Table 23. Americas Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Country (2017-2022) & ($ Millions)

Table 24. Americas Macular Degeneration (AMD) and Other Retinal Diseases Market Size Market Share by Country (2017-2022)

Table 25. Americas Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Type (2017-2022) & ($ Millions)

Table 26. Americas Macular Degeneration (AMD) and Other Retinal Diseases Market Size Market Share by Type (2017-2022)

Table 27. Americas Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Application (2017-2022) & ($ Millions)

Table 28. Americas Macular Degeneration (AMD) and Other Retinal Diseases Market Size Market Share by Application (2017-2022)

Table 29. APAC Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Region (2017-2022) & ($ Millions)

Table 30. APAC Macular Degeneration (AMD) and Other Retinal Diseases Market Size Market Share by Region (2017-2022)

Table 31. APAC Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Type (2017-2022) & ($ Millions)

Table 32. APAC Macular Degeneration (AMD) and Other Retinal Diseases Market Size Market Share by Type (2017-2022)

Table 33. APAC Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Application (2017-2022) & ($ Millions)

Table 34. APAC Macular Degeneration (AMD) and Other Retinal Diseases Market Size Market Share by Application (2017-2022)

Table 35. Europe Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Country (2017-2022) & ($ Millions)

Table 36. Europe Macular Degeneration (AMD) and Other Retinal Diseases Market Size Market Share by Country (2017-2022)

Table 37. Europe Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Type (2017-2022) & ($ Millions)

Table 38. Europe Macular Degeneration (AMD) and Other Retinal Diseases Market Size Market Share by Type (2017-2022)

Table 39. Europe Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Application (2017-2022) & ($ Millions)

Table 40. Europe Macular Degeneration (AMD) and Other Retinal Diseases Market Size Market Share by Application (2017-2022)

Table 41. Middle East & Africa Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Region (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Macular Degeneration (AMD) and Other Retinal Diseases Market Size Market Share by Region (2017-2022)

Table 43. Middle East & Africa Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Type (2017-2022) & ($ Millions)

Table 44. Middle East & Africa Macular Degeneration (AMD) and Other Retinal Diseases Market Size Market Share by Type (2017-2022)

Table 45. Middle East & Africa Macular Degeneration (AMD) and Other Retinal Diseases Market Size by Application (2017-2022) & ($ Millions)

Table 46. Middle East & Africa Macular Degeneration (AMD) and Other Retinal Diseases Market Size Market Share by Application (2017-2022)

Table 47. Key Market Drivers & Growth Opportunities of Macular Degeneration (AMD) and Other Retinal Diseases

Table 48. Key Market Challenges & Risks of Macular Degeneration (AMD) and Other Retinal Diseases

Table 49. Key Industry Trends of Macular Degeneration (AMD) and Other Retinal Diseases

Table 50. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 51. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size Market Share Forecast by Regions (2023-2028)

Table 52. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 53. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size Market Share Forecast by Type (2023-2028)

Table 54. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 55. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size Market Share Forecast by Application (2023-2028)

Table 56. Regeneron Pharmaceuticals Details, Company Type, Macular Degeneration (AMD) and Other Retinal Diseases Area Served and Its Competitors

Table 57. Regeneron Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Product Offered

Table 58. Regeneron Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 59. Regeneron Pharmaceuticals Main Business

Table 60. Regeneron Pharmaceuticals Latest Developments

Table 61. Bayer HealthCare Details, Company Type, Macular Degeneration (AMD) and Other Retinal Diseases Area Served and Its Competitors

Table 62. Bayer HealthCare Macular Degeneration (AMD) and Other Retinal Diseases Product Offered

Table 63. Bayer HealthCare Main Business

Table 64. Bayer HealthCare Macular Degeneration (AMD) and Other Retinal Diseases Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Bayer HealthCare Latest Developments

Table 66. Novartis Details, Company Type, Macular Degeneration (AMD) and Other Retinal Diseases Area Served and Its Competitors

Table 67. Novartis Macular Degeneration (AMD) and Other Retinal Diseases Product Offered

Table 68. Novartis Main Business

Table 69. Novartis Macular Degeneration (AMD) and Other Retinal Diseases Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Novartis Latest Developments

Table 71. Roche Details, Company Type, Macular Degeneration (AMD) and Other Retinal Diseases Area Served and Its Competitors

Table 72. Roche Macular Degeneration (AMD) and Other Retinal Diseases Product Offered

Table 73. Roche Main Business

Table 74. Roche Macular Degeneration (AMD) and Other Retinal Diseases Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. Roche Latest Developments

Table 76. Kanghong Pharma Details, Company Type, Macular Degeneration (AMD) and Other Retinal Diseases Area Served and Its Competitors

Table 77. Kanghong Pharma Macular Degeneration (AMD) and Other Retinal Diseases Product Offered

Table 78. Kanghong Pharma Main Business

Table 79. Kanghong Pharma Macular Degeneration (AMD) and Other Retinal Diseases Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. Kanghong Pharma Latest Developments

Table 81. Merck Details, Company Type, Macular Degeneration (AMD) and Other Retinal Diseases Area Served and Its Competitors

Table 82. Merck Macular Degeneration (AMD) and Other Retinal Diseases Product Offered

Table 83. Merck Main Business

Table 84. Merck Macular Degeneration (AMD) and Other Retinal Diseases Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. Merck Latest Developments

Table 86. Allergan Details, Company Type, Macular Degeneration (AMD) and Other Retinal Diseases Area Served and Its Competitors

Table 87. Allergan Macular Degeneration (AMD) and Other Retinal Diseases Product Offered

Table 88. Allergan Main Business

Table 89. Allergan Macular Degeneration (AMD) and Other Retinal Diseases Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. Allergan Latest Developments

Table 91. Santen Pharmaceutical Details, Company Type, Macular Degeneration (AMD) and Other Retinal Diseases Area Served and Its Competitors

Table 92. Santen Pharmaceutical Macular Degeneration (AMD) and Other Retinal Diseases Product Offered

Table 93. Santen Pharmaceutical Main Business

Table 94. Santen Pharmaceutical Macular Degeneration (AMD) and Other Retinal Diseases Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. Santen Pharmaceutical Latest Developments

Table 96. GlaxoSmithKline Pharmaceuticals Details, Company Type, Macular Degeneration (AMD) and Other Retinal Diseases Area Served and Its Competitors

Table 97. GlaxoSmithKline Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Product Offered

Table 98. GlaxoSmithKline Pharmaceuticals Main Business

Table 99. GlaxoSmithKline Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. GlaxoSmithKline Pharmaceuticals Latest Developments

Table 101. Pfizer Details, Company Type, Macular Degeneration (AMD) and Other Retinal Diseases Area Served and Its Competitors

Table 102. Pfizer Macular Degeneration (AMD) and Other Retinal Diseases Product Offered

Table 103. Pfizer Main Business

Table 104. Pfizer Macular Degeneration (AMD) and Other Retinal Diseases Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 105. Pfizer Latest Developments

Table 106. Acucela Details, Company Type, Macular Degeneration (AMD) and Other Retinal Diseases Area Served and Its Competitors

Table 107. Acucela Macular Degeneration (AMD) and Other Retinal Diseases Product Offered

Table 108. Acucela Macular Degeneration (AMD) and Other Retinal Diseases Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 109. Acucela Main Business

Table 110. Acucela Latest Developments

Table 111. Valent Pharmaceuticals Details, Company Type, Macular Degeneration (AMD) and Other Retinal Diseases Area Served and Its Competitors

Table 112. Valent Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Product Offered

Table 113. Valent Pharmaceuticals Main Business

Table 114. Valent Pharmaceuticals Macular Degeneration (AMD) and Other Retinal Diseases Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 115. Valent Pharmaceuticals Latest Developments

Table 116. IVERIC Details, Company Type, Macular Degeneration (AMD) and Other Retinal Diseases Area Served and Its Competitors

Table 117. IVERIC Macular Degeneration (AMD) and Other Retinal Diseases Product Offered

Table 118. IVERIC Main Business

Table 119. IVERIC Macular Degeneration (AMD) and Other Retinal Diseases Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 120. IVERIC Latest Developments

List of Figures

Figure 1. Macular Degeneration (AMD) and Other Retinal Diseases Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size Market Share by Type in 2021

Figure 7. Macular Degeneration (AMD) and Other Retinal Diseases in Hospital

Figure 8. Global Macular Degeneration (AMD) and Other Retinal Diseases Market: Hospital (2017-2022) & ($ Millions)

Figure 9. Macular Degeneration (AMD) and Other Retinal Diseases in Clinic

Figure 10. Global Macular Degeneration (AMD) and Other Retinal Diseases Market: Clinic (2017-2022) & ($ Millions)

Figure 11. Macular Degeneration (AMD) and Other Retinal Diseases in Other

Figure 12. Global Macular Degeneration (AMD) and Other Retinal Diseases Market: Other (2017-2022) & ($ Millions)

Figure 13. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size Market Share by Application in 2021

Figure 14. Global Macular Degeneration (AMD) and Other Retinal Diseases Revenue Market Share by Player in 2021

Figure 15. Global Macular Degeneration (AMD) and Other Retinal Diseases Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Macular Degeneration (AMD) and Other Retinal Diseases Market Size 2017-2022 ($ Millions)

Figure 17. APAC Macular Degeneration (AMD) and Other Retinal Diseases Market Size 2017-2022 ($ Millions)

Figure 18. Europe Macular Degeneration (AMD) and Other Retinal Diseases Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Macular Degeneration (AMD) and Other Retinal Diseases Market Size 2017-2022 ($ Millions)

Figure 20. Americas Macular Degeneration (AMD) and Other Retinal Diseases Value Market Share by Country in 2021

Figure 21. Americas Macular Degeneration (AMD) and Other Retinal Diseases Consumption Market Share by Type in 2021

Figure 22. Americas Macular Degeneration (AMD) and Other Retinal Diseases Market Size Market Share by Application in 2021

Figure 23. United States Macular Degeneration (AMD) and Other Retinal Diseases Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Macular Degeneration (AMD) and Other Retinal Diseases Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Macular Degeneration (AMD) and Other Retinal Diseases Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Macular Degeneration (AMD) and Other Retinal Diseases Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Macular Degeneration (AMD) and Other Retinal Diseases Market Size Market Share by Region in 2021

Figure 28. APAC Macular Degeneration (AMD) and Other Retinal Diseases Market Size Market Share by Application in 2021

Figure 29. China Macular Degeneration (AMD) and Other Retinal Diseases Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Macular Degeneration (AMD) and Other Retinal Diseases Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Macular Degeneration (AMD) and Other Retinal Diseases Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Macular Degeneration (AMD) and Other Retinal Diseases Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Macular Degeneration (AMD) and Other Retinal Diseases Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Macular Degeneration (AMD) and Other Retinal Diseases Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Macular Degeneration (AMD) and Other Retinal Diseases Market Size Market Share by Country in 2021

Figure 36. Europe Macular Degeneration (AMD) and Other Retinal Diseases Market Size Market Share by Type in 2021

Figure 37. Europe Macular Degeneration (AMD) and Other Retinal Diseases Market Size Market Share by Application in 2021

Figure 38. Germany Macular Degeneration (AMD) and Other Retinal Diseases Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Macular Degeneration (AMD) and Other Retinal Diseases Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Macular Degeneration (AMD) and Other Retinal Diseases Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Macular Degeneration (AMD) and Other Retinal Diseases Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Macular Degeneration (AMD) and Other Retinal Diseases Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Macular Degeneration (AMD) and Other Retinal Diseases Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Macular Degeneration (AMD) and Other Retinal Diseases Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Macular Degeneration (AMD) and Other Retinal Diseases Market Size Market Share by Application in 2021

Figure 46. Egypt Macular Degeneration (AMD) and Other Retinal Diseases Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Macular Degeneration (AMD) and Other Retinal Diseases Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Macular Degeneration (AMD) and Other Retinal Diseases Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Macular Degeneration (AMD) and Other Retinal Diseases Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Macular Degeneration (AMD) and Other Retinal Diseases Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Macular Degeneration (AMD) and Other Retinal Diseases Market Size 2023-2028 ($ Millions)

Figure 52. APAC Macular Degeneration (AMD) and Other Retinal Diseases Market Size 2023-2028 ($ Millions)

Figure 53. Europe Macular Degeneration (AMD) and Other Retinal Diseases Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Macular Degeneration (AMD) and Other Retinal Diseases Market Size 2023-2028 ($ Millions)

Figure 55. United States Macular Degeneration (AMD) and Other Retinal Diseases Market Size 2023-2028 ($ Millions)

Figure 56. Canada Macular Degeneration (AMD) and Other Retinal Diseases Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Macular Degeneration (AMD) and Other Retinal Diseases Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Macular Degeneration (AMD) and Other Retinal Diseases Market Size 2023-2028 ($ Millions)

Figure 59. China Macular Degeneration (AMD) and Other Retinal Diseases Market Size 2023-2028 ($ Millions)

Figure 60. Japan Macular Degeneration (AMD) and Other Retinal Diseases Market Size 2023-2028 ($ Millions)

Figure 61. Korea Macular Degeneration (AMD) and Other Retinal Diseases Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Macular Degeneration (AMD) and Other Retinal Diseases Market Size 2023-2028 ($ Millions)

Figure 63. India Macular Degeneration (AMD) and Other Retinal Diseases Market Size 2023-2028 ($ Millions)

Figure 64. Australia Macular Degeneration (AMD) and Other Retinal Diseases Market Size 2023-2028 ($ Millions)

Figure 65. Germany Macular Degeneration (AMD) and Other Retinal Diseases Market Size 2023-2028 ($ Millions)

Figure 66. France Macular Degeneration (AMD) and Other Retinal Diseases Market Size 2023-2028 ($ Millions)

Figure 67. UK Macular Degeneration (AMD) and Other Retinal Diseases Market Size 2023-2028 ($ Millions)

Figure 68. Italy Macular Degeneration (AMD) and Other Retinal Diseases Market Size 2023-2028 ($ Millions)

Figure 69. Russia Macular Degeneration (AMD) and Other Retinal Diseases Market Size 2023-2028 ($ Millions)

Figure 70. Spain Macular Degeneration (AMD) and Other Retinal Diseases Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Macular Degeneration (AMD) and Other Retinal Diseases Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Macular Degeneration (AMD) and Other Retinal Diseases Market Size 2023-2028 ($ Millions)

Figure 73. Israel Macular Degeneration (AMD) and Other Retinal Diseases Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Macular Degeneration (AMD) and Other Retinal Diseases Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Macular Degeneration (AMD) and Other Retinal Diseases Market Size 2023-2028 ($ Millions)